1 |
Arvind R, Shimamoto H, Momose F, et al (2005). A mutation in the common docking domain of ERK2 in a human cancer cell line, which was associated with its constitutive phosphorylation. Int J Oncol, 27, 1499-504.
|
2 |
Bazley LA, Gullick WJ (2005). The epidermal growth factor receptor family. Endocr Relat Cancer, 12, 17-27.
DOI
ScienceOn
|
3 |
de Melker AA, van der Horst G, Borst J (2004). Ubiquitin ligase activity of c-Cbl guides the epidermal growth factor receptor into clathrin-coated pits by two distinct modes of Eps15 recruitment. J Biol Chem, 279, 55465-73.
DOI
ScienceOn
|
4 |
Caligiuri MA, Briesewitz R, Yu J, et al (2007). Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia. Blood, 110, 1022-4.
DOI
ScienceOn
|
5 |
Fekrazad R, Hakimiha N, Farokhi E, et al (2011). Treatment of oral squamous cell carcinoma using anti-HER2 immunonanoshells. Int J Nanomedicine, 6, 2749-55.
|
6 |
Glogowska A, Stetefeld J, Weber E, et al (2012). Epidermal growth factor cytoplasmic domain affects ErbB protein degradation by the lysosomal and ubiquitin-proteasome pathway in human cancer cells. Neoplasia, 14, 396-409.
|
7 |
Gupta R, Ratan A, Rajesh C, et al (2012). Sequencing and analysis of a South Asian-Indian personal genome. BMC Genomics, 13, 440.
DOI
|
8 |
Jayaraman B, Valiathan GM, Jayakumar K, et al (2012). Lack of mutation in p53 and H-ras genes in phenytoin induced gingival overgrowth suggests its non cancerous nature. Asian Pac J Cancer Prev, 13, 5535-8.
과학기술학회마을
DOI
ScienceOn
|
9 |
Jiang N, Saba NF, Chen ZG (2012). Advances in targeting her3 as an anticancer therapy. Chemother Res Pract, 817, 304.
|
10 |
Mahalingam M, Arvind R, Ida H, et al (2008). ERK2 CD domain mutation from a human cancer cell line enhanced anchorage-independent cell growth and abnormality in Drosophila. Oncol Rep, 20, 957-62.
|
11 |
Mosesson Y, Shtiegman K, Katz M, et al (2003). Endocytosis of receptor tyrosine kinases is driven by monoubiquitylation, not polyubiquitylation. J Biol Chem, 278, 21323-6.
DOI
ScienceOn
|
12 |
Muramatsu H, Makishima H, Jankowska AM, et al (2010). Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia. Blood, 115, 1969-75.
DOI
ScienceOn
|
13 |
Nau MM, Lipkowitz S (2003). Comparative genomic organization of the cbl genes. Gene, 308, 103-13.
DOI
ScienceOn
|
14 |
Ogawa S, Shih LY, Suzuki T, et al (2010). Deregulated intracellular signaling by mutated c-CBL in myeloid neoplasms. Clin Cancer Res, 16, 3825-31.
DOI
|
15 |
Ryan PE, Sivadasan-Nair N, Nau MM, Nicholas S, Lipkowitz S (2010). The N terminus of Cbl-c regulates ubiquitin ligase activity by modulating affinity for the ubiquitin-conjugating enzyme. J Biol Chem, 285, 23687-98.
DOI
ScienceOn
|
16 |
Papagiorgis PC, Zizi AE, Tseleni S, Oikonomakis IN, Nikiteas NI (2012). The pattern of epidermal growth factor receptor variation with disease progression and aggressiveness in colorectal cancer depends on tumor location. Oncol Lett, 3, 1129-35.
|
17 |
Reich D, Thangaraj K, Patterson N, Price AL, Singh L (2009). Reconstructing Indian population history. Nature, 461, 489-94.
DOI
ScienceOn
|
18 |
Rubin C, Gur G, Yarden Y (2005). Negative regulation of receptor tyrosine kinases: unexpected links to c-Cbl and receptor ubiquitylation. Cell Res, 15, 66-71.
DOI
ScienceOn
|
19 |
Sorkin A, Goh LK (2009). Endocytosis and intracellular trafficking of ErbBs. Exp Cell Res, 315, 683-96.
DOI
ScienceOn
|
20 |
Swaminathan G, Tsygankov AY (2006). The Cbl family proteins: ring leaders in regulation of cell signaling. J Cell Physiol, 209, 21-43.
DOI
ScienceOn
|
21 |
Tan YH, Krishnaswamy S, Nandi S, et al (2010). CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases. PLoS One, 5, 8972.
DOI
ScienceOn
|
22 |
Visser GD, Lill NL (2005). The Cbl RING finger C-terminal flank controls epidermal growth factor receptor fate downstream of receptor ubiquitination. Exp Cell Res, 311, 281-93.
DOI
ScienceOn
|
23 |
Visser Smit GD, Place TL, Cole SL, et al (2009). Cbl controls EGFR fate by regulating early endosome fusion. Sci Signal, 102, 86.
|